For pharmacists, from Drug Topics: News stories for pharmacists about Rx and OTC products for treatment of illnesses ranging from the common cold to cancer
February 9, 2012
By:From staff reports
An FDA advisory panel recommended against using denosumab (Xgeva, Amgen) to delay or prevent the spread of castration-resistant prostate cancer at risk for bone metastases. The FDA?s Oncologic Drugs Advisory Committee concluded that the drug offered a statistical benefit but not a clinical benefit.
 |
February 9, 2012
By:From staff reports
Commercial electronic prescribing systems can significantly reduce medication errors in the hospital setting, according to a study published in PLoS Medicine in January
|
February 9, 2012
By:From staff reports
The American Society of Health Systems Pharmacists published a new guide cardiovascular care meant to help pharmacists and other healthcare providers save lives in emergency settings
|
February 7, 2012
By:From staff reports
FDA has granted priority review to crofelemer 125-mg tablets (Salix Pharmaceuticals) for the control and symptomatic relief of diarrhea in patients with HIV/AIDS on anti-retroviral therapy (ART).
|
February 3, 2012
By:From staff reports
FDA approved sitagliptin and metformin hydrochloride (HCl) extended-release (Janumet XR, Merck) tablets, a new treatment for type 2 diabetes that combines sitagliptin, which is the active component of Januvia (sitagliptin), with extended-release metformin.
|
February 2, 2012
By:From staff reports
Nursing home residents with dementia who use average doses of selective serotonin reuptake inhibitors (SSRIs) are 3 times more likely to have a fall resulting in injury compared with those who don?t use SSRIs, according a study published online January 18 in the British Journal of Clinical Pharmacology.
|
February 2, 2012
By:From staff reports
Researchers are warning pediatricians, pediatric hospitalists, and intensivists of the potential for intravenous acetaminophen dosing errors, especially in young patients under 2 years old.
|
February 2, 2012
By:From staff reports
FDA has approved linagliptin/metformin hydrochloride (Jentadueto, Boehringer Ingelheim and Eli Lilly) tablets, a new tablet that provides a single-tablet treatment option, taken twice-daily, for adult patients who need to control their blood sugar.
|
February 2, 2012
By:From staff reports
Dutasteride (Avodart, GlaxoSmithKline) delays the progression of prostate cancer in men with low-risk prostate cancer, according to a new study.
|
| 
| Drug Topics is a monthly news magazine, guided by a board of pharmacy leaders, reporting on all phases of community, retail, and health-system issues and trends. We cover managed care and professional, national, and state activities as well as new therapies involving prescription and OTC drugs.
|
ARCHIVES | RSS | E-NEWS | DIGITAL EDITION|
 | | | |
| Do you agree that pharmacists should have the authority to prescribe medications? | | | Yes | | 72% | | | No | | 28% | |
| |  | | | |
|
|
  Drug Topics archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.
Keep visiting Drug Topics for fresh content, news, opinions, editor's blogs and more.  | 
